Sign in

CIK 0001781174

  • Emerging growth company

Acrivon Therapeutics, Inc.

Sign in to watch
Ticker
ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
825125532
Phone
+1 617-207-8979
Business address
480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
  1. 4 Shares withheld for taxes Chief Legal Officer gave up 184 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP - Business Operations gave up 490 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 368 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Development Officer gave up 402 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Operating Officer gave up 613 shares (to pay taxes)
  6. 4 Shares withheld for taxes President and CEO gave up 54,918 shares (to pay taxes)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Shares withheld for taxes Chief Legal Officer gave up 558 shares (to pay taxes)
  9. 4 Grant or award Director acquired 3,530,000 shares (grant or award)
  10. 4 Open-market buy 10% owner bought 2,353,000 shares at $8.50 ($20,000,500)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Shares withheld for taxes Chief Legal Officer gave up 217 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP - Business Operations gave up 579 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Financial Officer gave up 434 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Development Officer gave up 468 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Operating Officer gave up 723 shares (to pay taxes)
  18. 4 Shares withheld for taxes President and CEO gave up 41,861 shares (to pay taxes)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 8 of 11 · 206 filings